News Conference News TCT 2023 Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80 Michael O'Riordan November 01, 2023
News Conference News TCT 2023 PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions L.A. McKeown October 31, 2023
Presentation TCT 2023 IV Antiplatelet Therapy in Cardiogenic Shock and Arrest: Insights from the CAMEO Registry Presenter: Jennifer Rymer October 26, 2023
Presentation TCT 2023 Antiplatelet Therapy in AMI and Cardiogenic Shock: National Cardiogenic Shock Initiative Presenter: Babar Basir October 26, 2023
Presentation TCT 2023 TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation Presenter: Masaru Ishida October 26, 2023
Presentation TCT 2023 TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis Presenter: Aakash Garg October 25, 2023
Presentation TCT 2023 TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction. Presenter: Hyunki LEE October 25, 2023
News Conference News TCT 2023 In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS Yael L. Maxwell October 25, 2023
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
News Conference News TCT 2023 ‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big Todd Neale October 25, 2023
Presentation TCT 2023 TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium Presenter: Seong Huan Choi October 25, 2023
Presentation TCT 2023 TCT 603: Single versus Dual Antiplatelet Therapy for Conservatively Managed Spontaneous Coronary Artery Dissection (SCAD) Patients Presenter: Sophie Offen October 25, 2023
Presentation TCT 2023 TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention Presenter: Ji-Yeon Kim October 25, 2023
Presentation TCT 2023 TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation Presenter: Byeong-Keuk Kim October 25, 2023
Presentation TCT 2023 Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial Presenter: Myeong-Ki Hong October 25, 2023
Presentation TCT 2023 TCT 7: Strategy of Dual Antiplatelet Therapy for Patients With ST elevation myocardial infarction or Non-ST elevation Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis Presenter: Toshiki Kuno October 24, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
Presentation TCT 2023 TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation Presenter: Daniel Overduin October 24, 2023
Presentation TCT 2023 Guided Antiplatelet Therapy: Why, and in Whom? Presenter: Jurrien Ten Berg October 24, 2023
Presentation TCT 2023 Long Term Maintenance Antiplatelet Therapy After PCI Presenter: Hyo-Soo Kim October 24, 2023